Home Cart 0 Sign in  

[ CAS No. 1315020-11-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1315020-11-1
Chemical Structure| 1315020-11-1
Structure of 1315020-11-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1315020-11-1 ]

Related Doc. of [ 1315020-11-1 ]

Alternatived Products of [ 1315020-11-1 ]

Product Details of [ 1315020-11-1 ]

CAS No. :1315020-11-1 MDL No. :MFCD08234637
Formula : C5H9NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :NOGODPXRSZBASZ-SCSAIBSYSA-N
M.W : 131.13 Pubchem ID :55252549
Synonyms :

Calculated chemistry of [ 1315020-11-1 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.8
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 33.68
TPSA : 49.77 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.61 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.03
Log Po/w (XLOGP3) : -0.72
Log Po/w (WLOGP) : -0.95
Log Po/w (MLOGP) : -0.82
Log Po/w (SILICOS-IT) : -0.32
Consensus Log Po/w : -0.36

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.13
Solubility : 96.4 mg/ml ; 0.736 mol/l
Class : Very soluble
Log S (Ali) : 0.15
Solubility : 186.0 mg/ml ; 1.42 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : 0.37
Solubility : 310.0 mg/ml ; 2.37 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.29

Safety of [ 1315020-11-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1315020-11-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1315020-11-1 ]

[ 1315020-11-1 ] Synthesis Path-Downstream   1~6

  • 1
  • [ 1315020-11-1 ]
  • [ 98-59-9 ]
  • [ 1217612-25-3 ]
YieldReaction ConditionsOperation in experiment
94% Stage #1: (5R)-5-(hydroxymethyl)-3-methyl-1,3-oxazolidin-2-one With trimethylamine hydrochloride; triethylamine In dichloromethane at 0℃; for 0.166667h; Stage #2: p-toluenesulfonyl chloride In dichloromethane at 20℃; 6DA [(5R)-3-methyl-2-oxo-1,3-oxazolidin-5-yl]methyl 4-methylbenzenesulfonate A mixture of Intermediate 159 (2.74 g, 20.9 mmo[), TEA (4.4 mL, 31 mmo[) andtrimethy[amine hydroch[oride (200 mg, 2.09 mmo[) in DCM (61 mL) was coo[ed to0°C and stirred for 10 minutes. 4-Methy[benzenesu[fony[ ch[oride (4.38 g, 23.0mmo[) was added in 3 portions and the so[ution stirred at RT unti[ comp[ete conversion. The reaction mixture was treated with N,N-dimethy[ethy[enediamine (2.7 mL, 25 mmo[) to consume unreacted 4-methy[benzenesu[fony[ ch[oride. Water was added, the aqueous phase extracted with DCM (three times) and the combined organic [ayers concentrated to dryness to give 5.97 g (94% yie[d) of the tit[ecompound, which was used without further purification.1H NMR (400 MHz, DMSO-d6): ö ppm 2.43 (5, 3 H) 2.66 - 2.73 (m, 3 H) 3.17 (dd, 1 H)3.57 (t, 1 H) 4.09 - 4.17 (m, 1 H) 4.18 - 4.25 (m, 1 H) 4.69 (dt, 1 H) 7.47 - 7.55 (m,2 H) 7.75 - 7.85 (m, 2 H).
  • 2
  • [ 254436-44-7 ]
  • [ 105-58-8 ]
  • [ 1315020-11-1 ]
YieldReaction ConditionsOperation in experiment
27% With potassium <i>tert</i>-butylate at 100℃; for 24h; 159 (5R)-5-(hydroxymethyl)-3-methyl-1,3-oxazolidin-2-one To a so[ution of Intermediate 158 (2.58 g, 24.5 mmo[) in diethy[ carbonate (18 mL, 150 mmo[) was added potassium tert-butoxide (138 mg, 1.23 mmo[). The reaction mixture was stirred for 24h at 100°C and evaporated to dryness. The residue was purified by co[umn chromatography (si[ica ge[, EtOAc/ hexane gradient) to give 861mg (27% yie[d) of the tit[e compound.1H NMR (400 MHz, DMSO-d6): ö [ppm] 2.72 (5, 3 H) 3.27 (dd, 1 H) 3.47 (dd, 1 H) 3.49- 3.58 (m, 2 H) 4.40 - 4.51 (m, 1 H) 5.10 (t, 1 H).
  • 3
  • [ 1315020-11-1 ]
  • [ 1948235-89-9 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1.1: triethylamine; trimethylamine hydrochloride / dichloromethane / 0.17 h / 0 °C 1.2: 20 °C 2.1: caesium carbonate / N,N-dimethyl-formamide / 90 °C
  • 4
  • [ 1315020-11-1 ]
  • [ 1948236-18-7 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1.1: triethylamine; trimethylamine hydrochloride / dichloromethane / 0.17 h / 0 °C 1.2: 20 °C 2.1: caesium carbonate / N,N-dimethyl-formamide / 90 °C 3.1: sodium hydroxide / methanol; water; tetrahydrofuran / 20 °C
  • 5
  • [ 1315020-11-1 ]
  • [ 140479-00-1 ]
YieldReaction ConditionsOperation in experiment
29% With pyridine; thionyl chloride In 1,2-dichloro-ethane at 90℃; for 1h; Intermediate 18: (R)-5-(chloromethyl)-3-methyloxazolidin-2-one. To (R)-5-(hydroxymethyl)-3-methyloxazolidin-2-one (518.2 mg, 3.952 mmol) stirring in DCE (20 mL) in a round bottom flask at rt was added SOCL (1.5 mL, 20.677 mmol) followed by pyridine (1.6 mL, 19.863 mmol). The reaction was connected to a reflux apparatus and stirred at 90 °C for 1 h. The reaction mixture was then cooled to rt, then cooled to 0 °C and quenched by the dropwise addition of a saturated aqueous solution of NaHCCb until pH 7 was reached. The layers were separated and the organic layer was washed with saturated aqueous solutions of NaHCCb (x 3), MLCl (x 3), then CuSCb (x 2). The organic layer was then dried (Na2SCb) and concentrated under reduced pressure to afford the title compound as a yellow oil (172.2 mg, 29%). NMR (500 MHz, CDCb) d 4.70 (dddd, J= 8.7, 7.0, 5.7, 4.1 Hz, 1H), 3.78 - 3.59 (m, 3H), 3.46 (dd, J= 9.0, 5.7 Hz, 1H), 2.90 (s, 3H).
With pyridine; thionyl chloride In 1,2-dichloro-ethane at 90℃; for 1h; Intermediate 18: (R)-5-(Chloromethyl)-3-methyloxazolidin-2-one To (R)-5-(hydroxymethyl)-3-methyloxazolidin-2-one (518.2 mg, 3.952 mmol) stirring in DCE (20 mL) in a round bottom flask at rt was added SOCl2 (1.5 mL, 20.677 mmol) followed by pyridine (1.6 mL, 19.863 mmol). The reaction was connected to a reflux apparatus and stirred at 90° C. for 1 h. The reaction mixture was then cooled to rt, then cooled to 0° C. and quenched by the dropwise addition of a saturated aqueous solution of NaHCO3 until pH 7 was reached. The layers were separated and the organic layer was washed with saturated aqueous solutions of NaHCO3 (*3), NH4C1 (*3), then CuSO4 (*2). The organic layer was then dried (Na2SO4) and concentrated under reduced pressure to afford the title compound as a yellow oil (172.2 mg, 29%). 1H NMR (500 MHz, CDCl3) δ 4.70 (dddd, J=8.7, 7.0, 5.7, 4.1 Hz, 1H), 3.78-3.59 (m, 3H), 3.46 (dd, J=9.0, 5.7 Hz, 1H), 2.90 (s, 3H).
  • 6
  • [ 1315020-11-1 ]
  • [ 2567041-82-9 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: thionyl chloride; pyridine / 1,2-dichloro-ethane / 1 h / 90 °C 2: caesium carbonate / N,N-dimethyl-formamide / 20 h / 20 °C
Multi-step reaction with 2 steps 1: thionyl chloride; pyridine / 1,2-dichloro-ethane / 1 h / 90 °C 2: caesium carbonate / N,N-dimethyl-formamide / 20 h / 20 °C
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1315020-11-1 ]

Alcohols

Chemical Structure| 637343-86-3

[ 637343-86-3 ]

(S)-5-(Hydroxymethyl)-3-methyloxazolidin-2-one

Similarity: 1.00

Chemical Structure| 637343-47-6

[ 637343-47-6 ]

(S)-3-Ethyl-5-(hydroxymethyl)oxazolidin-2-one

Similarity: 0.98

Chemical Structure| 83277-30-9

[ 83277-30-9 ]

5-(Hydroxymethyl)-3-isopropyloxazolidin-2-one

Similarity: 0.96

Chemical Structure| 68430-37-5

[ 68430-37-5 ]

(R)-5-(Hydroxymethyl)-3-isopropyloxazolidin-2-one

Similarity: 0.96

Chemical Structure| 68430-29-5

[ 68430-29-5 ]

(S)-5-(Hydroxymethyl)-3-isopropyloxazolidin-2-one

Similarity: 0.96

Amides

Chemical Structure| 637343-47-6

[ 637343-47-6 ]

(S)-3-Ethyl-5-(hydroxymethyl)oxazolidin-2-one

Similarity: 0.98

Chemical Structure| 83277-30-9

[ 83277-30-9 ]

5-(Hydroxymethyl)-3-isopropyloxazolidin-2-one

Similarity: 0.96

Chemical Structure| 68430-37-5

[ 68430-37-5 ]

(R)-5-(Hydroxymethyl)-3-isopropyloxazolidin-2-one

Similarity: 0.96

Chemical Structure| 68430-29-5

[ 68430-29-5 ]

(S)-5-(Hydroxymethyl)-3-isopropyloxazolidin-2-one

Similarity: 0.96

Chemical Structure| 637343-93-2

[ 637343-93-2 ]

(R)-5-(Aminomethyl)-3-methyloxazolidin-2-one

Similarity: 0.91

Related Parent Nucleus of
[ 1315020-11-1 ]

Oxazolidines

Chemical Structure| 637343-86-3

[ 637343-86-3 ]

(S)-5-(Hydroxymethyl)-3-methyloxazolidin-2-one

Similarity: 1.00

Chemical Structure| 637343-47-6

[ 637343-47-6 ]

(S)-3-Ethyl-5-(hydroxymethyl)oxazolidin-2-one

Similarity: 0.98

Chemical Structure| 83277-30-9

[ 83277-30-9 ]

5-(Hydroxymethyl)-3-isopropyloxazolidin-2-one

Similarity: 0.96

Chemical Structure| 68430-37-5

[ 68430-37-5 ]

(R)-5-(Hydroxymethyl)-3-isopropyloxazolidin-2-one

Similarity: 0.96

Chemical Structure| 68430-29-5

[ 68430-29-5 ]

(S)-5-(Hydroxymethyl)-3-isopropyloxazolidin-2-one

Similarity: 0.96